Zobrazeno 1 - 10
of 632
pro vyhledávání: '"Woloszczuk, W"'
Publikováno v:
In Bone 2003 32(6):681-686
Autor:
Bobacz, K †, Maier, R ‡, Fialka, C §, Ekhart, H †, Woloszczuk, W ∥, Geyer, G ∥, Erlacher, L †, Smolen, J †, Graninger, W.B †
Publikováno v:
In Osteoarthritis and Cartilage 2003 11(9):665-672
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 86:361-364
Since the role of gonadal steroids and their interrelation with calcium regulating hormones is not clear, we performed a prospective study to investigate the effects of gonadectomy on the calcitonin (CT)/katacalcin (KT) system using 1 minute calcium
Autor:
O'Brien M, Woloszczuk W
Publikováno v:
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen, Vol 13, Iss 1, Pp 9-12 (2006)
Publikováno v:
Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen, Vol 10, Iss 3, Pp 10-12 (2003)
Osteoprotegerin (OPG) wird in der entzündeten Synovialis bei chronischer Polyarthritis von Makrophagen, dendritischen Zellen und B-Zellen produziert. OPG hemmt die Differenzierung von Osteoklasten und ihre Aktivierung durch die Bindung an RANKL (rec
Autor:
Polyzos, S.A. Anastasilakis, A.D. Bratengeier, C. Woloszczuk, W. Papatheodorou, A. Terpos, E.
Sclerostin is expressed by osteocytes and inhibits bone formation by osteoblasts. In this study, serum sclerostin was positively correlated with either lumbar spinal bone mineral density or T-score. Furthermore, serum sclerostin was increased after 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fc200499aa3609d0e3097fea8ebcf145
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3149608
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3149608
Autor:
Andreas Gleiss, Wendlova J, S. Kudlacek, Katharina Kerschan-Schindl, Peter Pietschmann, Woloszczuk W
Publikováno v:
Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 116(8)
Background: Osteoporosis is one of the most common conditions associated with aging. It is based on an excess of bone resorption over bone formation, leading to an imbalance of bone turnover. The receptor activator of nuclear factor κB ligand (RANKL
Autor:
Schett, G., Kiechl, S., Bonora, Enzo, Redlich, K., Woloszczuk, W., Oberhollenzer, F., Jocher, J., Dorizzi, R., Muggeo, Michele, Smolen, J., Willeit, J.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1943::c2db68355a26cbe3ef062ca6c93e18c7
http://hdl.handle.net/11562/303846
http://hdl.handle.net/11562/303846